221 related articles for article (PubMed ID: 17121887)
1. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.
Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL
Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887
[TBL] [Abstract][Full Text] [Related]
2. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
[TBL] [Abstract][Full Text] [Related]
3. Expression and methylation status of the Syk gene in cervical carcinoma.
Zhao S; Sun G; Tony PW; Ma D; Zhao C
Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
[TBL] [Abstract][Full Text] [Related]
4. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
6. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
[TBL] [Abstract][Full Text] [Related]
8. Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis.
Yamada S; Nomoto S; Fujii T; Takeda S; Kanazumi N; Sugimoto H; Nakao A
Anticancer Res; 2007; 27(4B):2269-74. PubMed ID: 17695513
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between promoter methylation of Syk and Runx3 genes and postoperative recurrence and metastasis in gastric carcinoma].
Hong H; Zhou K; Fu P; Huang Q; Wang J; Yuan X; Li J
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):341-5. PubMed ID: 25030588
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Lee KH; Kim BH; Lee S; Lee HS; Jang JJ; Kang GH
Lab Invest; 2014 Dec; 94(12):1396-405. PubMed ID: 25310533
[TBL] [Abstract][Full Text] [Related]
11. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.
Wang S; Ding YB; Chen GY; Xia JG; Wu ZY
World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
14. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY
Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
Chan DW; Lee JM; Chan PC; Ng IO
Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma.
Du ZM; Kou CW; Wang HY; Huang MY; Liao DZ; Hu CF; Chen J; Yan LX; Hu LF; Ernberg I; Zeng YX; Shao JY
Head Neck; 2012 Oct; 34(10):1456-64. PubMed ID: 22287277
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of Klotho expression correlates with poor prognosis of human hepatocellular carcinoma.
Xie B; Zhou J; Yuan L; Ren F; Liu DC; Li Q; Shu G
Hum Pathol; 2013 May; 44(5):795-801. PubMed ID: 23123137
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of E-cadherin, CD34 in the patients with hepatocellular carcinoma].
Wu LQ; Lu Y; Lu HJ; Zhang B; Yang JY; Ma X
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):774-7. PubMed ID: 16836930
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
Yuan Y; Mendez R; Sahin A; Dai JL
Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
[TBL] [Abstract][Full Text] [Related]
20. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]